BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17173069)

  • 1. Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells.
    Grabarczyk P; Przybylski GK; Depke M; Völker U; Bahr J; Assmus K; Bröker BM; Walther R; Schmidt CA
    Oncogene; 2007 May; 26(26):3797-810. PubMed ID: 17173069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteome analysis reveals new mechanisms of Bcl11b-loss driven apoptosis.
    Karanam NK; Grabarczyk P; Hammer E; Scharf C; Venz S; Gesell-Salazar M; Barthlen W; Przybylski GK; Schmidt CA; Völker U
    J Proteome Res; 2010 Aug; 9(8):3799-811. PubMed ID: 20513151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response.
    Jiang CC; Chen LH; Gillespie S; Kiejda KA; Mhaidat N; Wang YF; Thorne R; Zhang XD; Hersey P
    Cancer Res; 2007 Jun; 67(12):5880-8. PubMed ID: 17575157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter.
    Cismasiu VB; Adamo K; Gecewicz J; Duque J; Lin Q; Avram D
    Oncogene; 2005 Oct; 24(45):6753-64. PubMed ID: 16091750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The modulating effect of proapoptotic protein Bax on the resistance of malignant lymphoma cells to tumor necrosis factor related apoptosis inducing ligand-induced apoptosis].
    Hao JH; Yu M; Jia L; Liu FT; Li Q; Hao XS
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):134-7. PubMed ID: 17418025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK
    Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral cancer cell lines can use multiple ligands, including Fas-L, TRAIL and TNF-alpha, to induce apoptosis in Jurkat T cells: possible mechanisms for immune escape by head and neck cancers.
    Kassouf N; Thornhill MH
    Oral Oncol; 2008 Jul; 44(7):672-82. PubMed ID: 17996489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down regulation of BCL11B expression inhibits proliferation and induces apoptosis in malignant T cells by BCL11B-935-siRNA.
    Huang X; Chen S; Shen Q; Chen S; Yang L; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
    Hematology; 2011 Jul; 16(4):236-42. PubMed ID: 21756541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells.
    Taniguchi H; Yoshida T; Horinaka M; Yasuda T; Goda AE; Konishi M; Wakada M; Kataoka K; Yoshikawa T; Sakai T
    Cancer Res; 2008 Nov; 68(21):8918-27. PubMed ID: 18974136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rottlerin induces apoptosis via death receptor 5 (DR5) upregulation through CHOP-dependent and PKC delta-independent mechanism in human malignant tumor cells.
    Lim JH; Park JW; Choi KS; Park YB; Kwon TK
    Carcinogenesis; 2009 May; 30(5):729-36. PubMed ID: 19037087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression level of Bcl-XL critically affects sensitivity of hepatocellular carcinoma cells to LIGHT-enhanced and interferon-gamma-induced apoptosis.
    Li J; Shen F; Wu D; Wei LX; Wang YZ; Shi LH; Zou Y; Wu MC
    Oncol Rep; 2007 May; 17(5):1067-75. PubMed ID: 17390046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HELIOS-BCL11B fusion gene involvement in a t(2;14)(q34;q32) in an adult T-cell leukemia patient.
    Fujimoto R; Ozawa T; Itoyama T; Sadamori N; Kurosawa N; Isobe M
    Cancer Genet; 2012; 205(7-8):356-64. PubMed ID: 22867996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies.
    Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED
    Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EphB receptors trigger Akt activation and suppress Fas receptor-induced apoptosis in malignant T lymphocytes.
    Maddigan A; Truitt L; Arsenault R; Freywald T; Allonby O; Dean J; Narendran A; Xiang J; Weng A; Napper S; Freywald A
    J Immunol; 2011 Dec; 187(11):5983-94. PubMed ID: 22039307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line.
    Casagrande G; te Kronnie G; Basso G
    Haematologica; 2006 Jun; 91(6):765-71. PubMed ID: 16769578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of Bid is associated with PKCepsilon-mediated TRAIL resistance.
    Sivaprasad U; Shankar E; Basu A
    Cell Death Differ; 2007 Apr; 14(4):851-60. PubMed ID: 17186022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death.
    Meslin F; Hamaï A; Gao P; Jalil A; Cahuzac N; Chouaib S; Mehrpour M
    Cancer Res; 2007 Nov; 67(22):10910-9. PubMed ID: 18006836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRAIL-induced apoptosis of FHIT-negative lung cancer cells is inhibited by FHIT re-expression.
    Mirandola P; Gobbi G; Sponzilli I; Malinverno C; Cavazzoni A; Alfieri R; Petronini PG; Vitale M
    J Cell Physiol; 2009 Aug; 220(2):492-8. PubMed ID: 19418484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5.
    Zhang Y; Zhang B
    Mol Cancer Res; 2008 Dec; 6(12):1861-71. PubMed ID: 19074831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression.
    Prado-Garcia H; Aguilar-Cazares D; Meneses-Flores M; Morales-Fuentes J; Lopez-Gonzalez JS
    Cancer Immunol Immunother; 2008 Mar; 57(3):325-36. PubMed ID: 17668204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.